WAYNE, Pa., May 09, 2024 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX), a global leader in medical technologies and pioneer in intraosseous vascular access, today announced the launch of the ...
Potential Savings of $95 Million Annually if Only Ten Percent of Central Lines Are Replaced with IO Access Success rate of 96% in establishing vascular access on first attempt; Mean time to vascular ...
Teleflex Corporation TFX recently announced that the FDA has granted 510(k) clearance to e Arrow EZ-IO Needle — the first and only intraosseous (IO) needle — for MR Conditional labeling. The ...
WAYNE, Pa., May 09, 2024 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX), a global leader in medical technologies and pioneer in intraosseous vascular access, today announced the launch of the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback